1 report a case of active retinitis in an infant with cytomegalovirus (CMV) infection. The authors acknowledge that it is difficult to distinguish between congenital or postnatally acquired CMV but exclude congenital infection due to the timing of the samples (virus isolation in urine before 28 days of life and positive CMV DNA in saliva, plasma and whole blood on day 34 of life), maternal serology and a negative CMV result from the dried blood spot (DBS).
Our data in the United Kingdom have shown that a negative DBS does not exclude congenital CMV (cCMV) infection. We have shown the sensitivity of DBS for retrospective diagnosis of cCMV in two well-defined laboratory confirmed groups to be 72% and 74%, respectively.
2 A large prospective study in the USA assessed the diagnostic accuracy of DBS PCR as a universal screening tool for cCMV.
3 This study showed that DBS PCR has low sensitivity for accurate diagnosis of cCMV as two-thirds of infections were missed. Moreover, our data as part of the Viral Load and Immunity in congenital cytomegalovirus study along with that published elsewhere shows that up to 25% of congenitally infected babies are not viraemic at birth using standard diagnostic CMV PCR techniques (Kimberlin et al. 4 and unpublished data). The maternal serology reported serves only to exclude a primary infection within 4 months of sampling. This does not therefore exclude maternal seroconversion early in this pregnancy. Furthermore, symptomatic cCMV has been well described in CMV seropositive women secondary to either maternal reactivation or reinfection. 5 We therefore suggest that the authors cannot exclude cCMV in this case study and that a negative DBS result does not exclude cCMV infection.
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The authors declare no conflict of interest. We have reported on a baby who had a difficult management because of the incongruity between the severe clinical symptoms and maternal history that lacked evidence of active infection during pregnancy. We are grateful to Dr Atkinson for the interest in our work and for the opportunity of discussion. The sensitivity of dried blood spot (DBS) tests in detecting congenital cytomegalovirus that are described in English studies (74.2% and 71.8%) refer to populations of, respectively, 31 and 39 neonates, 1 therefore, not wide enough to lead to a definite conclusion about the accuracy of the test. The conclusion is in fact the same as we proposed in the discussion of the management of our patient: if the DBS test is negative, this will help in excluding a congenital infection whenever the other clinical and laboratory data of both the neonate and the mother are consistent. Limits derive from the PCR method used, from the viral load in the blood, from quality of the DBS and finally from the time elapsed since the time of sampling.
In the case we described, the mother had a stable serology during pregnancy with high affinity at the time of hospitalisation of the neonate in our unit. Furthermore, PCR was negative in the mother's breast milk, saliva, urine and blood. We had, therefore, no evidence of a reactivation or an active infection during pregnancy. Finally we analysed the DBS test of the baby that resulted negative, confirming the hypothesis previously made of a postnatal infection. Is it important to highlight that the baby had received a blood transfusion at 15 days of life, before the diagnosis of retinitis was established.
In conclusion, as the DBS test exam has a variable sensitivity ranging from 49.5 to 100% 2 and considering that only few specialised laboratories can achieve a correct extraction and purification of the viral DNA, 3 we believe that it cannot be used as a routine exam for the diagnosis of congenital cytomegalovirus Journal of Perinatology (2013 ) 33, 495-496 & 2013 Nature America, Inc. All rights reserved 0743-8346/13 www.nature.com/jp
